Explore
Validate
LearnABIN395556
antibody from antibodies-online
Targeting: RAD51
BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [3]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN395556 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-DNA Repair Protein Homolog 1 (RAD51) (AA 1-243) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-243
- Isotype
- IgG
- Antibody clone number
- 2E5-E5
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis.
RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.
Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk.
Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population.
Zhou GW, Hu J, Peng XD, Li Q
Breast cancer research and treatment 2011 Jan;125(2):529-35
Breast cancer research and treatment 2011 Jan;125(2):529-35
RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.
Gao LB, Pan XM, Li LJ, Liang WB, Zhu Y, Zhang LS, Wei YG, Tang M, Zhang L
Breast cancer research and treatment 2011 Feb;125(3):827-35
Breast cancer research and treatment 2011 Feb;125(3):827-35
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.
Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, Bibeau F, Boissière-Michot F, Thezenas S, Cellier D, Azria D, Rouanet P, Senesse P, Ychou M, Lopez-Crapez E
The pharmacogenomics journal 2011 Dec;11(6):437-43
The pharmacogenomics journal 2011 Dec;11(6):437-43
Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk.
Liu Y, Shete S, Wang LE, El-Zein R, Etzel CJ, Liang FW, Armstrong G, Tsavachidis S, Gilbert MR, Aldape KD, Xing J, Wu X, Wei Q, Bondy ML
Carcinogenesis 2010 Oct;31(10):1762-9
Carcinogenesis 2010 Oct;31(10):1762-9
Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population.
Sliwinski T, Walczak A, Przybylowska K, Rusin P, Pietruszewska W, Zielinska-Blizniewska H, Olszewski J, Morawiec-Sztandera A, Jendrzejczyk S, Mlynarski W, Majsterek I
Experimental and molecular pathology 2010 Dec;89(3):358-66
Experimental and molecular pathology 2010 Dec;89(3):358-66
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
